Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
26.44
+0.10 (0.38%)
Oct 19, 2026, 10:43 AM EDT - Market open
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $3.32 billion as of October 19, 2026. It is the 4,830th most valuable company in the world and the 1,421st biggest in the United States. Its market cap has increased by 108.10% in one year.
Market Cap
3.32B
Enterprise Value
3.07B
1-Year Change
108.10%
Global Rank
Country Rank
#1,421 United States
Category
ChartMarket Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $3.32B, an increase of 210.38%. That is a compound annual growth rate of 26.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 3.32B | 150.15% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regencell Bioscience Holdings | 4.76B |
| Indivior Pharmaceuticals | 3.83B |
| Liquidia | 3.07B |
| HUTCHMED (China) | 2.52B |
| Prestige Consumer Healthcare | 2.36B |
| Bausch Health Companies | 2.36B |
| Perrigo Company | 2.31B |
| Supernus Pharmaceuticals | 2.20B |